Rhode Island Diastolic Dysfunction - Heart Failure

Description

To study the hypothesis that treating patients with underlying diastolic dysfunction with oral Kuvan® (BH4, also known as tetrahydrobiopterin) in addition to current best practices will improve metabolic and echocardiographic diastolic function parameters.

Study Start Date

March 2015

Estimated Completion Date

December 2018

Interventions

  • Drug: Kuvan

Specialties

  • Cardiology: Arrhythmias/EP,Diagnostics,Heart Failure,Interventional,Vascular Medicine
  • Internal Medicine: Cardiology
  • Nursing: Cardiology
  • Physician Assistant: Cardiology

MeSH Terms

  • Cardiovascular Diseases
  • Heart Failure

Study ID

Providence VA Medical Center -- 2014-051

Status

Unknown

Trial ID

NCT02353312

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

30

Sponsor

Providence VA Medical Center

Inclusion Criteria

    1. Male and female U.S. Veteran patients over the age of eighteen, with echocardiographic findings of >= Grade 2 diastolic dysfunction [as per American Society of Echocardiography guidelines] and 2. Diagnosis of hypertension, diabetes, or heart failure in medical records. 3. Eligible subjects must be ambulatory (not dependent on any ambulatory assist devices including cane or walker).

Exclusion Criteria

    1. Any history of documented ejection fraction <50% 2. Significant COPD (defined as oxygen-dependent COPD) 3. Acute coronary syndrome within the past three months defined by EKG changes and biomarkers of myocardial necrosis (ie. elevated troponin) in the setting of chest pain or an anginal equivalent) 4. Presence of hypertrophic cardiomyopathy 5. Presence of infiltrative/restrictive cardiomyopathy 6. Echocardiographic evidence of moderate or severe aortic or mitral valve stenosis or regurgitation 7. Previously diagnosed phenylketonuria 8. End stage renal disease requiring hemodialysis 9. Pre-existing seizure disorder 10. Terminal illness (not including heart failure) with expected survival of one year or less 11. Females who are pregnant or breastfeeding. All females of child bearing age will undergo pregnancy testing prior to randomization. 12. Recent hospitalization within three months. 13. Previous Bioprosthetic and/or mechanical aortic or mitral valves

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Providence VAMC - Providence, Rhode Island 40.1 miles WenChih Wu MD 401-273-7100 wen-chih.wu@va.gov

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.